LESINURAD, A NOVEL SELECTIVE URIC ACID REABSORPTION INHIBITOR, IN COMBINATION WITH FEBUXOSTAT, IN PATIENTS WITH TOPHACEOUS GOUT: THE CRYSTAL PHASE III CLINICAL TRIAL

被引：12

作者：

Dalbeth, N. ^{[1
]}

Jones, G. ^{[2
]}

Terkeltaub, R. ^{[3
]}

Khanna, D. ^{[4
]}

Kopicko, J. ^{[5
]}

Bhakta, N. ^{[5
]}

Fung, M. ^{[5
]}

Storgard, C. ^{[5
]}

Baumgartner, S. ^{[5
]}

Perez-Ruiz, F. ^{[6
]}

机构：

[1] Univ Auckland, Auckland, New Zealand

[2] Univ Tasmania, Hobart, Tas, Australia

[3] Univ Calif San Diego, San Diego, CA 92103 USA

[4] Univ Michigan, Ann Arbor, MI 48109 USA

[5] Ardea Biosci Inc, San Diego, CA USA

[6] Hosp Univ Cruces, Baracaldo, Spain

来源：

关键词：

D O I：

10.1136/annrheumdis-2015-eular.2182

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

SAT0329

引用

页码：778 / 778

页数：1